GlassScriptPhysician profile
Sam Jones Cox
NPI 1114037546
$902.05
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2020: $141 · 2021: $242 · 2022: $143 · 2023: $72.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $72.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $72.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $279.50 | 2019-2022 | |
| Pfizer INC. | $111.28 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $94.79 | 2020-2023 | |
| Hologic Sales and Service, LLC | $73.01 | 2019-2020 | |
| Lupin INC. | $49.53 | 2021 | |
| Therapeuticsmd, INC. | $35.50 | 2019 | |
| Exeltis, USA INC. | $31.21 | 2019-2023 | Slynd |
| Allergan, INC. | $27.92 | 2019 | |
| Avion Pharmaceuticals | $25.74 | 2020-2021 | |
| Ascend Therapeutics US, LLC | $24.14 | 2020 | |
| Roche Diagnostics Corporation | $23.73 | 2019 | |
| Astellas Pharma US INC | $20.88 | 2021 | |
| Abbott Laboratories | $19.76 | 2023 | Ensite |
| Mayne Pharma Commercial LLC | $18.71 | 2022 | |
| Mylan Pharmaceuticals INC. | $14.71 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardinal Health 200 LLC | $14.63 | 2020 | |
| Idorsia Pharmaceuticals US INC | $12.97 | 2022 | |
| Boston Scientific Corporation | $12.73 | 2019 | |
| Evofem Biosciences, INC. | $11.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sam Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.